These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 2055340)

  • 1. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.
    Hartter E; Svoboda T; Ludvik B; Schuller M; Lell B; Kuenburg E; Brunnbauer M; Woloszczuk W; Prager R
    Diabetologia; 1991 Jan; 34(1):52-4. PubMed ID: 2055340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.
    Hanabusa T; Kubo K; Oki C; Nakano Y; Okai K; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 1992 Jan; 15(1):89-96. PubMed ID: 1541240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes.
    Ludvik B; Lell B; Hartter E; Schnack C; Prager R
    Diabetes; 1991 Dec; 40(12):1615-9. PubMed ID: 1756902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity.
    Mather KJ; Paradisi G; Leaming R; Hook G; Steinberg HO; Fineberg N; Hanley R; Baron AD
    Diabetes Metab Res Rev; 2002; 18(2):118-26. PubMed ID: 11994903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?
    Stadler M; Anderwald C; Karer T; Tura A; Kästenbauer T; Auinger M; Bieglmayer C; Wagner O; Kronenberg F; Nowotny P; Pacini G; Prager R
    Diabetes Care; 2006 May; 29(5):1031-8. PubMed ID: 16644633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients.
    Sanke T; Hanabusa T; Nakano Y; Oki C; Okai K; Nishimura S; Kondo M; Nanjo K
    Diabetologia; 1991 Feb; 34(2):129-32. PubMed ID: 2065848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes.
    Mäkimattila S; Fineman MS; Yki-Järvinen H
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2822-7. PubMed ID: 10946889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
    Rachman J; Payne MJ; Levy JC; Barrow BA; Holman RR; Turner RC
    Diabetes Care; 1998 May; 21(5):810-6. PubMed ID: 9589246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer.
    Mäkimattila S; Hietaniemi K; Kiviluoto T; Timonen T; Yki-Järvinen H
    Metabolism; 2001 Sep; 50(9):1036-42. PubMed ID: 11555835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible links between amylin and diabetes. Amylin is released into the blood stream along with insulin.
    Luskey KL
    Diabetes Care; 1992 Feb; 15(2):297-9. PubMed ID: 1547690
    [No Abstract]   [Full Text] [Related]  

  • 11. Release of amylin from perfused rat pancreas in response to glucose and glucagon.
    Inoue K; Hisatomi A; Umeda F; Nawata H
    Diabetes Res Clin Pract; 1992 Jan; 15(1):85-8. PubMed ID: 1541239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amylin/IAPP (islet amyloid polypeptide)--physiology and clinical significance].
    Ludvik B
    Wien Klin Wochenschr; 1997 Jun; 109(11):379-83. PubMed ID: 9281227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biological role of islet amyloid polypeptide (amylin) in diabetes: some recent results.
    Sandler S
    Diabetologia; 1994 Feb; 37(2):225-6. PubMed ID: 8163061
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of an islet amyloid polypeptide-like molecule.
    Stridsberg M; Berne C; Sandler S; Wilander E; Oberg K
    Diabetologia; 1993 Sep; 36(9):843-9. PubMed ID: 8405756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent diabetes mellitus (type 2).
    Zapecka-Dubno B; Czyzyk A; Dworak A; Bak MI
    Arzneimittelforschung; 1999 Apr; 49(4):330-4. PubMed ID: 10337452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus.
    Cooper GJ; Day AJ; Willis AC; Roberts AN; Reid KB; Leighton B
    Biochim Biophys Acta; 1989 Dec; 1014(3):247-58. PubMed ID: 2690958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment.
    Inoue K; Hisatomi A; Umeda F; Nawata H
    Diabetes; 1992 Jun; 41(6):723-7. PubMed ID: 1534057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans.
    Wilding JP; Khandan-Nia N; Bennet WM; Gilbey SG; Beacham J; Ghatei MA; Bloom SR
    Diabetologia; 1994 Feb; 37(2):166-9. PubMed ID: 8163050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats.
    Gedulin B; Cooper GJ; Young AA
    Biochem Biophys Res Commun; 1991 Oct; 180(2):782-9. PubMed ID: 1953751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Levy JC; Rudenski A; Burnett M; Knight R; Matthews DR; Turner RC
    Diabetologia; 1991 Jul; 34(7):488-99. PubMed ID: 1916054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.